INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,514,533 | +54.1% | 59,982 | +28.7% | 0.00% | – |
| Q2 2023 | $983,102 | +24.1% | 46,593 | +0.3% | 0.00% | – |
| Q1 2023 | $792,237 | +7.5% | 46,466 | +26.0% | 0.00% | – |
| Q4 2022 | $737,042 | -15.6% | 36,889 | -9.0% | 0.00% | – |
| Q3 2022 | $873,000 | +17.7% | 40,534 | +7.7% | 0.00% | – |
| Q2 2022 | $742,000 | -3.6% | 37,625 | +14.8% | 0.00% | – |
| Q1 2022 | $770,000 | -4.0% | 32,776 | +11.3% | 0.00% | – |
| Q4 2021 | $802,000 | +22.8% | 29,440 | +24.2% | 0.00% | – |
| Q3 2021 | $653,000 | +4.5% | 23,704 | +8.0% | 0.00% | – |
| Q2 2021 | $625,000 | -23.0% | 21,945 | -7.9% | 0.00% | -100.0% |
| Q1 2021 | $812,000 | +12.9% | 23,826 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $719,000 | +8.8% | 21,612 | +5.0% | 0.00% | 0.0% |
| Q3 2020 | $661,000 | +57.8% | 20,580 | +35.4% | 0.00% | – |
| Q2 2020 | $419,000 | +82.2% | 15,197 | +5.9% | 0.00% | – |
| Q1 2020 | $230,000 | – | 14,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |